tiprankstipranks
Trending News
More News >
ResMed price target lowered to $248 from $260 at Piper Sandler
PremiumThe FlyResMed price target lowered to $248 from $260 at Piper Sandler
7d ago
ResMed price target raised to $255 from $247 at RBC Capital
Premium
The Fly
ResMed price target raised to $255 from $247 at RBC Capital
7d ago
ResMed: Strong Financial Performance and Strategic Positioning Justify Buy Rating
Premium
Ratings
ResMed: Strong Financial Performance and Strategic Positioning Justify Buy Rating
7d ago
ResMed reports Q3 non-GAAP EPS $2.37, consensus $2.36
PremiumThe FlyResMed reports Q3 non-GAAP EPS $2.37, consensus $2.36
8d ago
ResMed appoints Salli Schwartz as Chief Investor Relations Officer
Premium
The Fly
ResMed appoints Salli Schwartz as Chief Investor Relations Officer
10d ago
ResMed price target lowered to $268 from $280 at KeyBanc
Premium
The Fly
ResMed price target lowered to $268 from $280 at KeyBanc
10d ago
ResMed placed on ‘downside 90-day catalyst watch’ at Citi
PremiumThe FlyResMed placed on ‘downside 90-day catalyst watch’ at Citi
20d ago
ResMed announces availability of home sleep apnea test NightOwl
Premium
The Fly
ResMed announces availability of home sleep apnea test NightOwl
28d ago
ResMed price target lowered to $280 from $290 at BofA
Premium
The Fly
ResMed price target lowered to $280 from $290 at BofA
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100